JP2015505244A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015505244A5 JP2015505244A5 JP2014549503A JP2014549503A JP2015505244A5 JP 2015505244 A5 JP2015505244 A5 JP 2015505244A5 JP 2014549503 A JP2014549503 A JP 2014549503A JP 2014549503 A JP2014549503 A JP 2014549503A JP 2015505244 A5 JP2015505244 A5 JP 2015505244A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- peptide
- antigen
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161580837P | 2011-12-28 | 2011-12-28 | |
| EP11195952.4 | 2011-12-28 | ||
| US61/580,837 | 2011-12-28 | ||
| EP11195952 | 2011-12-28 | ||
| PCT/EP2013/050024 WO2013098419A1 (en) | 2011-12-28 | 2013-01-02 | Method of providing monoclonal auto-antibodies with desired specificity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015505244A JP2015505244A (ja) | 2015-02-19 |
| JP2015505244A5 true JP2015505244A5 (enExample) | 2016-01-21 |
| JP6242808B2 JP6242808B2 (ja) | 2017-12-06 |
Family
ID=48696366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014549503A Expired - Fee Related JP6242808B2 (ja) | 2011-12-28 | 2013-01-02 | 所望の特異性を有するモノクローナル自己抗体を提供する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9957319B2 (enExample) |
| EP (3) | EP2797952B1 (enExample) |
| JP (1) | JP6242808B2 (enExample) |
| AU (3) | AU2013206789B2 (enExample) |
| CA (2) | CA2861695C (enExample) |
| DK (1) | DK2797951T3 (enExample) |
| ES (2) | ES2964168T3 (enExample) |
| HU (1) | HUE037186T2 (enExample) |
| PL (2) | PL2797952T3 (enExample) |
| PT (1) | PT2797951T (enExample) |
| SI (1) | SI2797952T1 (enExample) |
| WO (2) | WO2013098419A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10131709B2 (en) | 2011-12-28 | 2018-11-20 | Immunoqure Ag | Nucleic acid molecules encoding monoclonal antibodies specific for IL-22 |
| EP2626367A1 (en) * | 2012-02-10 | 2013-08-14 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Method for obtaining three-dimensional actin structures and uses thereof |
| US20140199319A1 (en) * | 2012-12-14 | 2014-07-17 | Abbvie, Inc. | Methods for increasing the efficiency of hybridoma generation |
| CA2917112C (en) | 2013-07-03 | 2022-07-05 | Immunoqure Ag | Human anti-ifn-alpha antibodies |
| WO2015001047A1 (en) | 2013-07-03 | 2015-01-08 | Immunoqure Ag | Method of providing anti-human cytokine antibodies for pharmaceutical use |
| EP3016977B1 (en) * | 2013-07-03 | 2019-10-23 | ImmunoQure AG | Human anti-il-32 antibodies |
| EP2863231A1 (en) * | 2013-10-17 | 2015-04-22 | Institut D'Investigaciones Biomédiques August Pi i Sunyer | Diagnostic method for detecting a GABA(A) related autoimmune disease and related subject-matter |
| KR20170027795A (ko) * | 2014-07-03 | 2017-03-10 | 이뮤노큐어 아게 | 항-사이토카인 항체의 동정을 위한 인간-유래 항-인간 il-20 항체 및 검정 |
| KR102441107B1 (ko) * | 2014-11-07 | 2022-09-13 | 후지쿠라 가세이 가부시키가이샤 | 데옥시하이푸신·신타제 유전자를 지표로서 사용하는 동맥 경화 및 암의 검출 방법 |
| PT3277321T (pt) | 2015-04-01 | 2024-09-17 | Anaptysbio Inc | Anticorpos dirigidos contra a proteína de imunoglobulina de células t e mucina 3 (tim-3) |
| MX2017013080A (es) | 2015-04-15 | 2018-02-09 | Anaptysbio Inc | Anticuerpos dirigidos contra receptor de interleucina 36 (il-36r). |
| CN108350071A (zh) * | 2015-08-17 | 2018-07-31 | 德国神经退行性疾病中心 | 结合到抗N-甲基-D-天冬氨酸(NMDA)受体抗体的结合区的抗体或抗体片段或非Ig支架 |
| FR3050535B1 (fr) * | 2016-04-25 | 2020-11-13 | Hospices Civils Lyon | Anticorps anti il17 |
| US20190183997A1 (en) * | 2016-07-22 | 2019-06-20 | University Of Washington | Identification and production of high affinity igm antibodies and derivatives thereof |
| CA3041685A1 (en) | 2016-11-01 | 2018-05-11 | Anaptysbio, Inc. | Antibodies directed against t cell immunoglobulin and mucin protein 3 (tim-3) |
| KR102671283B1 (ko) | 2017-01-09 | 2024-06-03 | 테사로, 인코포레이티드 | 항tim-3 항체로 암을 치료하는 방법 |
| US11619832B2 (en) | 2018-03-08 | 2023-04-04 | Coopervision International Limited | Identification of contact lens wearers predisposed to contact lens discomfort |
| AU2020205965A1 (en) | 2019-01-07 | 2021-07-01 | Shattuck Labs. Inc. | Heterodimeric proteins for modulating gamma delta T cells |
| US11098093B2 (en) | 2019-01-07 | 2021-08-24 | Shattuck Labs, Inc. | Heterodimeric proteins for modulating gamma delta T cells |
| WO2021250323A1 (en) * | 2020-06-09 | 2021-12-16 | Helsingin Yliopisto | Anti-cox-2 autoantibody as a diagnostic marker, and methods, kits and uses related thereto |
| EP4305190A4 (en) | 2021-03-11 | 2025-03-26 | Iggenix, Inc. | METHODS AND SYSTEMS FOR PREDICTING AN ALLERGIC REACTION |
| WO2023213400A1 (en) * | 2022-05-05 | 2023-11-09 | Institute For Research In Biomedicine | Antibodies against chemokines, method for identifying said antibodies and uses thereof |
| CN115724983B (zh) * | 2022-10-10 | 2023-09-19 | 宝船生物医药科技(上海)有限公司 | 一种针对抗csf1r单克隆抗体的抗独特型抗体及其应用 |
| TW202540204A (zh) | 2024-01-26 | 2025-10-16 | 西班牙商阿爾米雷爾有限公司 | 雙特異性分子及使用其的治療方法 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| AU612370B2 (en) | 1987-05-21 | 1991-07-11 | Micromet Ag | Targeted multifunctional proteins |
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| JPH02503867A (ja) | 1988-04-15 | 1990-11-15 | プロテイン デザイン ラブズ インコーポレーテッド | Ｉｌ‐２レセプター特異的キメラ抗体 |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| CA2050918A1 (en) | 1990-01-12 | 1991-07-13 | Raju Kucherlapati | Generation of xenogeneic antibodies |
| WO1996033735A1 (en) | 1995-04-27 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| GB9020282D0 (en) | 1990-09-17 | 1990-10-31 | Gorman Scott D | Altered antibodies and their preparation |
| DK9091D0 (da) | 1991-01-18 | 1991-01-18 | Novo Nordisk As | Fremgangsmaade til fremstilling af antistoffer |
| DE4130786A1 (de) * | 1991-09-16 | 1993-03-18 | Symbiotec Gmbh | Peptide zur herstellung von mitteln zur diagnose und therapie von systemischen lupus |
| JP2006008694A (ja) * | 1991-09-16 | 2006-01-12 | Symbiotec Ges Zur Forschung & Entwicklung Au F Dem Gebiet Der Biotechnologie Mbh | 全身性エリテマトーデスの診断、治療製剤製造用ペプチド |
| AU665221B2 (en) | 1991-12-02 | 1995-12-21 | Cambridge Antibody Technology Limited | Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| SG48760A1 (en) | 1992-07-24 | 2003-03-18 | Abgenix Inc | Generation of xenogenetic antibodies |
| DE69321962T2 (de) | 1992-08-21 | 1999-07-01 | Biogen Inc | Von tat abgeleitete transportpolypeptide |
| US6309636B1 (en) * | 1995-09-14 | 2001-10-30 | Cancer Research Institute Of Contra Costa | Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides |
| CA2219486A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| EP0776906A3 (de) * | 1995-10-19 | 1998-02-25 | Imtec Immundiagnostika Gmbh | Peptide des Antigens Sm-D und ihre Verwendung, insbesondere für die Diagnostik des SLE |
| US6590079B2 (en) | 1997-01-30 | 2003-07-08 | Ixsys, Incorporated | Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same |
| FI973762A0 (fi) | 1997-09-23 | 1997-09-23 | Krohn Kai | Ny gen |
| US6939545B2 (en) | 1999-04-28 | 2005-09-06 | Genetics Institute, Llc | Composition and method for treating inflammatory disorders |
| US6531580B1 (en) | 1999-06-24 | 2003-03-11 | Ixsys, Inc. | Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same |
| US6849425B1 (en) | 1999-10-14 | 2005-02-01 | Ixsys, Inc. | Methods of optimizing antibody variable region binding affinity |
| US6838250B2 (en) | 2000-03-31 | 2005-01-04 | Ortho-Clinical Diagnostics, Inc. | Immunoassay for C-reactive protein |
| US7638604B2 (en) * | 2001-02-23 | 2009-12-29 | Genetics Institute, Llc | Monoclonal antibodies against interleukin-22 |
| US20030044870A1 (en) | 2001-07-13 | 2003-03-06 | Peter Sehr | Generic capture elisa using recombinant fusion proteins for detecting antibodies in biological samples |
| WO2003099868A2 (en) | 2002-05-28 | 2003-12-04 | Omrix Biopharmaceuticals Inc. | Method for obtaining anti-idiotype antibodies |
| US20040101909A1 (en) | 2002-08-20 | 2004-05-27 | Hema-Quebec, 2535 Boul. Laurier, Ste-Foy, Quebec, Canada G1V 4M3 | Purification of polyreactive autoantibodies and uses thereof |
| EP1597280B2 (en) | 2003-02-26 | 2016-08-24 | Institute for Research in Biomedicine | Monoclonal antibody production by ebv transformation of b cells |
| GB0407315D0 (en) | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| US7158410B2 (en) | 2004-08-27 | 2007-01-02 | Micron Technology, Inc. | Integrated DRAM-NVRAM multi-level memory |
| ATE513034T1 (de) | 2005-12-16 | 2011-07-15 | Ribovax Biotechnologies Sa | Verfahren zur gewinnung immortalisierter antikörpersezernierender zellen |
| WO2007106769A2 (en) * | 2006-03-10 | 2007-09-20 | Zymogenetics, Inc. | Antibodies that bind both il-17a and il-17f and methods of using the same |
| TW200815469A (en) | 2006-06-23 | 2008-04-01 | Astrazeneca Ab | Compounds |
| JP4059404B2 (ja) * | 2006-09-22 | 2008-03-12 | 栄研化学株式会社 | 甲状腺機能を刺激する活性を持つ抗体 |
| SG177954A1 (en) * | 2007-01-05 | 2012-02-28 | Univ Zuerich | Method of providing disease-specific binding molecules and targets |
| EP2134746B1 (en) | 2007-03-13 | 2014-08-06 | University Of Zurich | Monoclonal human tumor-specific antibody |
| US7736648B2 (en) * | 2007-10-25 | 2010-06-15 | Trellis Bioscience, Inc. | Anti-RSV G protein antibodies |
| GB0807413D0 (en) * | 2008-04-23 | 2008-05-28 | Ucb Pharma Sa | Biological products |
| JP2011519911A (ja) * | 2008-05-05 | 2011-07-14 | ノヴィミュンヌ エスア | 抗ｉｌ１７ａ／ｉｌ−１７ｆ交差反応抗体及びその使用方法 |
| US20110171688A1 (en) | 2008-06-16 | 2011-07-14 | Christoph Esslinger | Method of providing immunoglobulin secreting b lymphocytes and human antibodies |
| ES2544569T3 (es) | 2008-12-19 | 2015-09-01 | Biogen International Neuroscience Gmbh | Autoanticuerpos humanos anti alfa-sinucleina |
| CN104974250A (zh) * | 2009-05-05 | 2015-10-14 | 诺维莫尼公司 | 抗il-17f抗体及其使用方法 |
| EP2258727A1 (en) | 2009-05-27 | 2010-12-08 | Wezen Biopharmaceuticals S.r.l. A Socio Unico | Immunoglobulin preparation for the treatment of autoimmune diseases and immune system disorders |
-
2013
- 2013-01-02 JP JP2014549503A patent/JP6242808B2/ja not_active Expired - Fee Related
- 2013-01-02 ES ES19159201T patent/ES2964168T3/es active Active
- 2013-01-02 CA CA2861695A patent/CA2861695C/en active Active
- 2013-01-02 EP EP13700013.9A patent/EP2797952B1/en active Active
- 2013-01-02 EP EP13700002.2A patent/EP2797951B1/en active Active
- 2013-01-02 WO PCT/EP2013/050024 patent/WO2013098419A1/en not_active Ceased
- 2013-01-02 WO PCT/EP2013/050026 patent/WO2013098420A1/en not_active Ceased
- 2013-01-02 PL PL13700013T patent/PL2797952T3/pl unknown
- 2013-01-02 PT PT137000022T patent/PT2797951T/pt unknown
- 2013-01-02 AU AU2013206789A patent/AU2013206789B2/en not_active Ceased
- 2013-01-02 SI SI201331457T patent/SI2797952T1/sl unknown
- 2013-01-02 ES ES13700002.2T patent/ES2668104T3/es active Active
- 2013-01-02 CA CA2861793A patent/CA2861793C/en active Active
- 2013-01-02 AU AU2013206788A patent/AU2013206788B2/en not_active Ceased
- 2013-01-02 DK DK13700002.2T patent/DK2797951T3/en active
- 2013-01-02 HU HUE13700002A patent/HUE037186T2/hu unknown
- 2013-01-02 EP EP19159201.3A patent/EP3546481B1/en active Active
- 2013-01-02 US US14/368,749 patent/US9957319B2/en active Active
- 2013-01-02 US US14/369,467 patent/US9475872B2/en not_active Expired - Fee Related
- 2013-01-02 PL PL13700002T patent/PL2797951T3/pl unknown
-
2017
- 2017-06-29 AU AU2017204449A patent/AU2017204449A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015505244A5 (enExample) | ||
| US12410256B2 (en) | Antibodies that specifically bind to TL1a and methods of treating gastrointestinal or lung diseases | |
| RU2474588C2 (ru) | Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения | |
| RU2016136639A (ru) | Антитела против эотаксина 2, которые распознают дополнительные связывающие CCR3 хемокины | |
| US9127057B2 (en) | Anti-IL-23 heterodimer specific antibodies | |
| US10894828B2 (en) | Immune-stimulating monoclonal antibodies against human interleukin-2 | |
| RU2018111508A (ru) | Анти-LAG-3 антитела | |
| RU2011149334A (ru) | Анти-il-17f антитела и способы их применения | |
| JP2018121657A5 (enExample) | ||
| RU2013153592A (ru) | Анти-mif антитела | |
| JP2020536488A5 (enExample) | ||
| SI2481753T1 (en) | Anti-IL-17 antibodies | |
| RU2013133846A (ru) | Антитела против il-18 и их применение | |
| RU2017107773A (ru) | Антитела, специфичные к ммр9 | |
| EP3026060A1 (en) | Humanized antibody or fragment thereof specific for CD45R0 | |
| JP2016503293A5 (enExample) | ||
| JP2012524524A5 (enExample) | ||
| CN101851291A (zh) | 一种抗人baff单克隆抗体的重链和轻链可变区 | |
| Du et al. | Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients | |
| TW201625947A (zh) | 測定ｆｖｉｉｉ的反應性之方法 | |
| US20200141947A1 (en) | Compositions and methods for treating age-related diabetes and related disorders | |
| Tsuboi et al. | Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor | |
| CN116554323A (zh) | 人源化抗il21抗体的开发和应用 | |
| WO2022197914A2 (en) | Stem cell factor antibodies and methods of use thereof | |
| Kerzel et al. | Unlike in children with allergic asthma, IgE transcripts from preschool children with atopic dermatitis display signs of superantigen-driven activation |